Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1991 Jan;66(1 Spec No):74–77. doi: 10.1136/adc.66.1_spec_no.74

Treatment of persistent pulmonary hypertension of the newborn: update.

Y K Abu-Osba 1
PMCID: PMC1590354  PMID: 1996900

Full text

PDF
74

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANSTALL H. B., HAYWARD G. H., HUNTSMAN R. G., WEITZMAN D., LEHMANN H. The effect of magnesium on blood coagulation in human subjects. Lancet. 1959 Apr 18;1(7077):814–815. doi: 10.1016/s0140-6736(59)92002-1. [DOI] [PubMed] [Google Scholar]
  2. Altura B. M., Altura B. T. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc. 1981 Oct;40(12):2672–2679. [PubMed] [Google Scholar]
  3. Altura B. T., Altura B. M. Interactions of Mg and K on cerebral vessels--aspects in view of stroke. Review of present status and new findings. Magnesium. 1984;3(4-6):195–211. [PubMed] [Google Scholar]
  4. Aveldano M. I., Bazán N. G. Rapid production of diacylglycerols enriched in arachidonate and stearate during early brain ischemia. J Neurochem. 1975 Dec;25(6):919–920. doi: 10.1111/j.1471-4159.1975.tb04432.x. [DOI] [PubMed] [Google Scholar]
  5. Bartlett R. H., Roloff D. W., Cornell R. G., Andrews A. F., Dillon P. W., Zwischenberger J. B. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985 Oct;76(4):479–487. [PubMed] [Google Scholar]
  6. Benitz W. E., Malachowski N., Cohen R. S., Stevenson D. K., Ariagno R. L., Sunshine P. Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr. 1985 Jan;106(1):102–110. doi: 10.1016/s0022-3476(85)80477-7. [DOI] [PubMed] [Google Scholar]
  7. Bohr D. F. The pulmonary hypoxic response. State of the field. Chest. 1977 Feb;71(2 Suppl):244–246. [PubMed] [Google Scholar]
  8. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  9. Clemens M. G., McDonagh P. F., Chaudry I. H., Baue A. E. Hepatic microcirculatory failure after ischemia and reperfusion: improvement with ATP-MgCl2 treatment. Am J Physiol. 1985 Jun;248(6 Pt 2):H804–H811. doi: 10.1152/ajpheart.1985.248.6.H804. [DOI] [PubMed] [Google Scholar]
  10. Cotton D. B., Gonik B., Dorman K. F. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol. 1984 Jan 15;148(2):162–165. doi: 10.1016/s0002-9378(84)80169-6. [DOI] [PubMed] [Google Scholar]
  11. Cropp G. J. Reduction of hypoxic pulmonary vasoconstriction by magnesium chloride. J Appl Physiol. 1968 Jun;24(6):755–760. doi: 10.1152/jappl.1968.24.6.755. [DOI] [PubMed] [Google Scholar]
  12. Davis J. M., Spitzer A. R., Cox C., Fox W. W. Predicting survival in infants with persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 1988;5(1):6–9. doi: 10.1002/ppul.1950050103. [DOI] [PubMed] [Google Scholar]
  13. Dickstein P. J., Trindade O., Goldberg R. N., Bancalari E. The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. Pediatr Res. 1984 Dec;18(12):1262–1265. doi: 10.1203/00006450-198412000-00007. [DOI] [PubMed] [Google Scholar]
  14. Ducas J., Duval D., Dasilva H., Boiteau P., Prewitt R. M. Treatment of canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics. Circulation. 1987 Jan;75(1):235–242. doi: 10.1161/01.cir.75.1.235. [DOI] [PubMed] [Google Scholar]
  15. FROHLICH E. D., SCOTT J. B., HADDY F. J. Effect of cations on resistance and responsiveness of renal and forelimb vascular beds. Am J Physiol. 1962 Sep;203:583–587. doi: 10.1152/ajplegacy.1962.203.3.583. [DOI] [PubMed] [Google Scholar]
  16. Fine R. N. Peritoneal dialysis update. J Pediatr. 1982 Jan;100(1):1–7. doi: 10.1016/s0022-3476(82)80226-6. [DOI] [PubMed] [Google Scholar]
  17. Fox W. W., Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr. 1983 Oct;103(4):505–514. doi: 10.1016/s0022-3476(83)80573-3. [DOI] [PubMed] [Google Scholar]
  18. Hammerman C., Komar K., Abu-Khudair H. Hypoxic vs septic pulmonary hypertension. Selective role of thromboxane mediation. Am J Dis Child. 1988 Mar;142(3):319–325. doi: 10.1001/archpedi.1988.02150030093030. [DOI] [PubMed] [Google Scholar]
  19. Haworth S. G., Reid L. Persistent fetal circulation: Newly recognized structural features. J Pediatr. 1976 Apr;88(4 Pt 1):614–620. doi: 10.1016/s0022-3476(76)80021-2. [DOI] [PubMed] [Google Scholar]
  20. Huszar G., Roberts J. M. Biochemistry and pharmacology of the myometrium and labor: regulation at the cellular and molecular levels. Am J Obstet Gynecol. 1982 Jan 15;142(2):225–237. doi: 10.1016/s0002-9378(16)32341-9. [DOI] [PubMed] [Google Scholar]
  21. Johnsson H. Effects of nifedipine (Adalat) on platelet function in vitro and in vivo. 1981 Feb 15-Mar 1Thromb Res. 21(4-5):523–528. doi: 10.1016/0049-3848(81)90155-9. [DOI] [PubMed] [Google Scholar]
  22. Karaki H., Kubota H., Urakawa N. Mobilization of stored calcium for phasic contraction induced by norepinephrine in rabbit aorta. Eur J Pharmacol. 1979 Jun 15;56(3):237–245. doi: 10.1016/0014-2999(79)90176-6. [DOI] [PubMed] [Google Scholar]
  23. Krummel T. M., Greenfield L. J., Kirkpatrick B. V., Mueller D. G., Kerkering K. W., Ormazabal M., Napolitano A., Salzberg A. M. Alveolar-arterial oxygen gradients versus the Neonatal Pulmonary Insufficiency Index for prediction of mortality in ECMO candidates. J Pediatr Surg. 1984 Aug;19(4):380–384. doi: 10.1016/s0022-3468(84)80257-2. [DOI] [PubMed] [Google Scholar]
  24. Käpä P., Koivisto M., Ylikorkala O., Kouvalainen K. Prostacyclin in the treatment of neonatal pulmonary hypertension. J Pediatr. 1985 Dec;107(6):951–953. doi: 10.1016/s0022-3476(85)80200-6. [DOI] [PubMed] [Google Scholar]
  25. Larsson L. E., Ekström-Jodal B., Hjalmarson O. The effect of chlorpromazine in severe hypoxia in newborn infants. Acta Paediatr Scand. 1982 May;71(3):399–402. doi: 10.1111/j.1651-2227.1982.tb09441.x. [DOI] [PubMed] [Google Scholar]
  26. Levin D. L., Weinberg A. G., Perkin R. M. Pulmonary microthrombi syndrome in newborn infants with unresponsive persistent pulmonary hypertension. J Pediatr. 1983 Feb;102(2):299–303. doi: 10.1016/s0022-3476(83)80547-2. [DOI] [PubMed] [Google Scholar]
  27. Levowitz B. S., Goldson H., Rashkin A., Kay H., Valcin A., Mathur A., LaGuerre J. N. Magnesium ion blockade of regional vasoconstriction. Ann Surg. 1970 Jul;172(1):33–40. [PMC free article] [PubMed] [Google Scholar]
  28. Lipman J., James M. F., Erskine J., Plit M. L., Eidelman J., Esser J. D. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med. 1987 Oct;15(10):987–988. [PubMed] [Google Scholar]
  29. Mathew R., Altura B. T., Altura B. M. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment. Magnesium. 1989;8(2):110–116. [PubMed] [Google Scholar]
  30. McMurtry I. F., Davidson A. B., Reeves J. T., Grover R. F. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res. 1976 Feb;38(2):99–104. doi: 10.1161/01.res.38.2.99. [DOI] [PubMed] [Google Scholar]
  31. Mélot C., Naeije R., Mols P., Vandenbossche J. L., Denolin H. Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest. 1983 Feb;83(2):203–207. doi: 10.1378/chest.83.2.203. [DOI] [PubMed] [Google Scholar]
  32. Paidas C. N., Dudgeon D. L., Haller J. A., Jr, Clemens M. G. Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg. 1988 Dec;23(12):1154–1160. doi: 10.1016/s0022-3468(88)80332-4. [DOI] [PubMed] [Google Scholar]
  33. Philips J. B., 3rd, Lyrene R. K., McDevitt M., Perlis W., Satterwhite C., Cassady G. Prostaglandin D2 inhibits hypoxic pulmonary vasoconstriction in neonatal lambs. J Appl Physiol Respir Environ Exerc Physiol. 1983 Jun;54(6):1585–1589. doi: 10.1152/jappl.1983.54.6.1585. [DOI] [PubMed] [Google Scholar]
  34. Philips J. B., 3rd Prostaglandins and related compounds in the perinatal pulmonary circulation. Pediatr Pharmacol (New York) 1984;4(2):129–142. [PubMed] [Google Scholar]
  35. Raj J. U., Chen P. Micropuncture measurement of microvascular pressures in isolated lamb lungs during hypoxia. Circ Res. 1986 Oct;59(4):398–404. doi: 10.1161/01.res.59.4.398. [DOI] [PubMed] [Google Scholar]
  36. Raj J. U., Chen P. Role of eicosanoids in hypoxic vasoconstriction in isolated lamb lungs. Am J Physiol. 1987 Sep;253(3 Pt 2):H626–H633. doi: 10.1152/ajpheart.1987.253.3.H626. [DOI] [PubMed] [Google Scholar]
  37. Reeves J. T., Groves B. M., Turkevich D. The case for treatment of selected patients with primary pulmonary hypertension. Am Rev Respir Dis. 1986 Aug;134(2):342–346. doi: 10.1164/arrd.1986.134.2.342. [DOI] [PubMed] [Google Scholar]
  38. Rimele T. J., Vanhoutte P. M. Effects of inhibitors of arachidonic acid metabolism and calcium entry on responses to acetylcholine, potassium and norepinephrine in the isolated canine saphenous vein. J Pharmacol Exp Ther. 1983 Jun;225(3):720–728. [PubMed] [Google Scholar]
  39. Rojas J., Green R. S., Hellerqvist C. G., Olegard R., Brigham K. L., Stahlman M. T. Studies on group B beta-hemolytic Streptococcus. II. Effects on pulmonary hemodynamics and vascular permeability in unanesthetized sheep. Pediatr Res. 1981 Jun;15(6):899–904. doi: 10.1203/00006450-198106000-00003. [DOI] [PubMed] [Google Scholar]
  40. Rudolph A. M. Fetal and neonatal pulmonary circulation. Annu Rev Physiol. 1979;41:383–395. doi: 10.1146/annurev.ph.41.030179.002123. [DOI] [PubMed] [Google Scholar]
  41. Sell E. J., Gaines J. A., Gluckman C., Williams E. Persistent fetal circulation. Neurodevelopmental outcome. Am J Dis Child. 1985 Jan;139(1):25–28. doi: 10.1001/archpedi.1985.02140030027020. [DOI] [PubMed] [Google Scholar]
  42. Turlapaty P. D., Altura B. M. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol. 1978 Dec 1;52(3-4):421–423. doi: 10.1016/0014-2999(78)90303-5. [DOI] [PubMed] [Google Scholar]
  43. Van Nueten J. M., Vanhoutte P. M. Improvement of tissue perfusion with inhibitors of calcium ion influx. Biochem Pharmacol. 1980 Feb 15;29(4):479–481. doi: 10.1016/0006-2952(80)90365-2. [DOI] [PubMed] [Google Scholar]
  44. Wegman M. E. Annual summary of vital statistics--1981. Pediatrics. 1982 Dec;70(6):835–843. [PubMed] [Google Scholar]
  45. White B. C., Winegar C. D., Wilson R. F., Krause G. S. Calcium blockers in cerebral resuscitation. J Trauma. 1983 Sep;23(9):788–794. doi: 10.1097/00005373-198309000-00003. [DOI] [PubMed] [Google Scholar]
  46. Wung J. T., James L. S., Kilchevsky E., James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics. 1985 Oct;76(4):488–494. [PubMed] [Google Scholar]
  47. van Nueten J. M., Vanhoutte P. M. Effect of the Ca2+ antagonist lidoflazine on normoxic and anoxic contractions of canine coronary arterial smooth muscle. Eur J Pharmacol. 1980 Jun 13;64(2-3):173–176. doi: 10.1016/0014-2999(80)90042-4. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES